Strategic market access and health policy expert with extensive experience in US and global pricing, access, and reimbursement for pharmaceuticals and medical devices. Skilled in developing value communication platforms and propositions that align with key value messages and data. Established network of payer stakeholders across national and regional MCOs, PBMs, IDNs, and ACOs.
Overview
22
22
years of professional experience
Work History
Global Marketing Director
Amgen
Thousand Oaks
05.2025 - Current
Led cross-functional integrated brand team to manage and implement launch readiness initiatives for global commercial launch of olpasiran, ensuring successful execution.
Created and led inaugural brand-working group (BWG) for olpasiran, integrating global-to-local considerations to facilitate successful affiliate commercial launch.
Developed global commercial and marketing strategies for innovative product targeting genetic risk factor in cardiovascular disease, aligning with market needs.
Senior Director, Global Market Access, Pricing, & Value Demonstration (GMAx)
Bristol Myers Squibb
Lawrenceville
07.2023 - Current
Led market access and pricing strategy for early commercial development and business development programs in cardiovascular, immunology, and neuroscience portfolios, ensuring alignment with market needs.
Acted as core team member for commercial disease strategy teams across CIN therapeutic areas, integrating access and pricing considerations into development processes and target indications.
Led strategic initiatives to enhance product development processes and timelines.
Directed cross-functional teams to ensure alignment on project objectives and deliverables.
Managed stakeholder relationships to facilitate effective communication and collaboration.
Senior Director, Global Market Access and Value Demonstration
Bellus Health
Laval
10.2022 - 07.2023
Developed internal capabilities for Commercial and Global Access and Pricing functions, enabling successful first commercial launch for Bellus Health.
Coordinated US and global market access planning and launch preparation for BLUE-5937, optimizing patient access and contributing to $2B exit to GSK in July 2023.
Directed strategic initiatives to enhance operational efficiency and innovation in healthcare solutions.
Collaborated with cross-functional teams to align product development with market needs.
Managed budget allocation for projects, ensuring optimal resource utilization across departments.
Director, Global Market Access, Pricing, & Value Demonstration (GMAx)
Bristol Myers Squibb
Lawrenceville
07.2021 - 10.2022
Led value, access, pricing, and HEOR strategies for development programs, ensuring incorporation of payer needs into early development plans and trial designs across cardiovascular, immunology, and fibrosis portfolios
Acted as the primary contact and leader for business development assessments across therapeutic areas, integrating access and pricing insights into due diligence processes and contractual negotiations.
Led cross-functional teams to implement strategic initiatives in healthcare innovation.
Developed and executed long-term business strategies to enhance market position.
Oversaw compliance with regulatory standards in pharmaceutical operations and practices.
WW Market Access Strategy Lead (MASL)
Bristol Myers Squibb
Lawrenceville
10.2020 - 07.2021
Developed integrated, worldwide market access strategy for in-line and pipeline oncology assets, with specific focus on biomarker access considerations
Extended Commercial team, collaborated with Medical, Business Insights, Analytics teams, and local markets to monitor external environment and synthesize input for Market Access Strategy throughout lifecycle
Completed day-to-day duties accurately and efficiently.
Contributed innovative ideas and solutions to enhance team performance and outcomes.
Worked successfully with diverse group of coworkers to accomplish goals and address issues related to our products and services.
Director, Value Insights and Access Strategy
Research Triangle Institute Health Solutions (RTI-HS)
Research Triangle Park
01.2016 - 10.2020
Led research initiatives to develop and train field personnel on payer value propositions, value messages, and cost-impact and value tools for provider and payer stakeholders, enhancing stakeholder engagement.
Designed and led primary research initiatives among provider and payer stakeholders in US and global markets, implementing qualitative interviews, surveys, and advisory boards to inform strategic insights.
Led strategic initiatives to enhance health solutions and research methodologies.
Collaborated with cross-functional teams to develop innovative healthcare programs.
Oversaw project management processes for multiple health research studies.
Director, Business Development
RTI Health Solutions
Research Triangle Park
04.2014 - 01.2016
Led client acquisition and resource management to expand commercial and market access opportunities
Expanded company footprint from HEOR to commercial functions within key pharmaceutical and medical device manufacturers
Developed strategic partnerships to enhance healthcare solutions and services.
Led market analysis to identify growth opportunities in health solutions sector.
Collaborated with cross-functional teams to align business development initiatives.
Research Analyst
Medical Marketing Economics
Oxford
04.2012 - 03.2014
Brand Manager and Dermatology Commercial Lead
Merz Pharmaceuticals
Greensboro
12.2009 - 08.2011
Associate Manager, Sale Training & Development
Johnson & Johnson
Los Angeles
12.2007 - 12.2009
Professional Sales Representative
Johnson & Johnson
Nashville
05.2004 - 12.2007
Education
PhD - Pharmacy Administration
University of Mississippi School of Pharmacy
Oxford, United States
Masters of Science - Applied Pharmacoeconomics
University of Florida College of Pharmacy
Gainesville, United States
Bachelor of Business Administration - Corporate Finance